Document Detail


Role of the ATFa/JNK2 complex in Jun activation.
MedLine Citation:
PMID:  10376527     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The ATFa proteins, which are members of the CREB/ATF family of transcription factors, display quite versatile properties. We have previously shown that they interact with the adenovirus E1a oncoprotein, mediating part of its transcriptional activity and heterodimerize with the Jun, Fos or related transcription factors, thereby modulating their DNA-binding specificity. In the present study, we report the sequence requirement of the N-terminal activation domain of ATFa and demonstrate the importance of specific threonine residues (Thr51 and Thr53) in addition to that of the metal-binding domain, in transcriptional activation processes. We also show that the N-terminal domain of ATFa which stably binds the Jun N-terminal kinase-2 (JNK2) (Bocco et al., 1996), is not a substrate for this kinase in vivo but, instead, serves as a JNK2-docking site for ATFa-associated partners like JunD, allowing them to be phosphorylated by the bound kinase.
Authors:
F De Graeve; A Bahr; K T Sabapathy; C Hauss; E F Wagner; C Kedinger; B Chatton
Related Documents :
19671797 - Inhibition of activator protein-1 by sulforaphane involves interaction with cysteine in...
20974807 - Molecular determinants for small maf protein control of platelet production.
9593667 - Nuclear factor i regulates expression of the gene for phosphoenolpyruvate carboxykinase...
25193767 - Getting the best out of the bva's new website.
3680237 - Characterization of pyridoxal 5'-phosphate affinity labeling of band 3 protein. evidenc...
9390557 - Cytochrome c and datp-dependent formation of apaf-1/caspase-9 complex initiates an apop...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Oncogene     Volume:  18     ISSN:  0950-9232     ISO Abbreviation:  Oncogene     Publication Date:  1999 Jun 
Date Detail:
Created Date:  1999-06-30     Completed Date:  1999-06-30     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  3491-500     Citation Subset:  IM    
Affiliation:
Institut de Génétique et de Biologie Moléculaire et Cellulaire, INSERM/CNRS/ULP, Illkirch, CU de Strasbourg, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Activating Transcription Factor 1
Animals
COS Cells
Cell Line
DNA-Binding Proteins*
Mitogen-Activated Protein Kinase 9
Mitogen-Activated Protein Kinases*
Peptide Fragments / physiology*
Phosphorylation
Protein Kinases / physiology*
Proto-Oncogene Proteins c-jun / metabolism
Transcription Factors / physiology*
Transcriptional Activation / physiology*
Chemical
Reg. No./Substance:
0/Activating Transcription Factor 1; 0/DNA-Binding Proteins; 0/Peptide Fragments; 0/Proto-Oncogene Proteins c-jun; 0/Transcription Factors; EC 2.7.-/Protein Kinases; EC 2.7.1.24/Mitogen-Activated Protein Kinase 9; EC 2.7.11.24/Mitogen-Activated Protein Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobu...
Next Document:  Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.